Table of Contents 2
List of Tables 5
List of Figures 5
Chiesi Farmaceutici SpA Spshot 6
Chiesi Farmaceutici SpA Overview 6
Key Facts 6
Chiesi Farmaceutici SpA - Research and Development Overview 7
Key Therapeutic Areas 7
Chiesi Farmaceutici SpA - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Combition Treatment Modalities 12
Pipeline Products - Partnered Products 13
Partnered Products/Combition Treatment Modalities 14
Pipeline Products - Out-Licensed Products 15
Out-Licensed Products/Combition Treatment Modalities 16
Chiesi Farmaceutici SpA - Pipeline Products Glance 17
Chiesi Farmaceutici SpA - Late Stage Pipeline Products 17
Phase III Products/Combition Treatment Modalities 17
Chiesi Farmaceutici SpA - Clinical Stage Pipeline Products 18
Phase II Products/Combition Treatment Modalities 18
Phase I Products/Combition Treatment Modalities 19
Chiesi Farmaceutici SpA - Early Stage Pipeline Products 20
Preclinical Products/Combition Treatment Modalities 20
Chiesi Farmaceutici SpA - Unknown Stage Pipeline Products 21
Unknown Products/Combition Treatment Modalities 21
Chiesi Farmaceutici SpA - Drug Profiles 22
(beclomethasone dipropiote + formoterol fumarate + glycopyrrolate) - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
budesonide - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
CHF-5633 - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
CHF-6001 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
CHF-6297 - Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
CPD-15 - Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
Drugs for Bronchopulmory Dysplasia - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
glycopyrrolate - Drug Profile 32
Product Description 32
Mechanism Of Action 32
R&D Progress 32
melatonin - Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
meropenem - Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
Recombint Enzymes for Rare Diseases - Drug Profile 36
Product Description 36
Mechanism Of Action 36
R&D Progress 36
Recombint Protein for Neotal Respiratory Distress Syndrome - Drug Profile 37
Product Description 37
Mechanism Of Action 37
R&D Progress 37
Recombint Protein to Target NGF for Undisclosed Indication - Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
Small Molecule to Inhibit Neutrophil Elastase for Respiratory Diseases - Drug Profile 39
Product Description 39
Mechanism Of Action 39
R&D Progress 39
Small Molecule to Target Beta 2 Adrenergic Receptor and Muscarinic Acetylcholine Receptor M3 for Asthma and COPD - Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40
Small Molecules for Neotal Abstinence Syndrome - Drug Profile 41
Product Description 41
Mechanism Of Action 41
R&D Progress 41
TRP-601 - Drug Profile 42
Product Description 42
Mechanism Of Action 42
R&D Progress 42
velmase alfa - Drug Profile 43
Product Description 43
Mechanism Of Action 43
R&D Progress 43
Chiesi Farmaceutici SpA - Pipeline Alysis 45
Chiesi Farmaceutici SpA - Pipeline Products by Target 45
Chiesi Farmaceutici SpA - Pipeline Products by Route of Administration 47
Chiesi Farmaceutici SpA - Pipeline Products by Molecule Type 48
Chiesi Farmaceutici SpA - Pipeline Products by Mechanism of Action 49
Chiesi Farmaceutici SpA - Dormant Projects 51
Chiesi Farmaceutici SpA - Discontinued Pipeline Products 52
Discontinued Pipeline Product Profiles 53
beclomethasone dipropiote SR 53
carmoterol 53
indantadol 53
Porphozym 53
Chiesi Farmaceutici SpA - Company Statement 54
Chiesi Farmaceutici SpA - Locations And Subsidiaries 56
Head Office 56
Other Locations & Subsidiaries 57
Appendix 60
Methodology 60
Coverage 60
Secondary Research 60
Primary Research 60
Expert Panel Validation 60
Contact Us 60
Disclaimer 61